Brentuximab Vedotin in Advanced Hodgkin's Lymphoma. Reply.

Autor: Ansell SM; Mayo Clinic, Rochester, MN ansell.stephen@mayo.edu., Radford J; University of Manchester, Manchester, United Kingdom., Straus DJ; Memorial Sloan Kettering Cancer Center, New York, NY.
Jazyk: angličtina
Zdroj: The New England journal of medicine [N Engl J Med] 2022 Oct 20; Vol. 387 (16), pp. 1527-1528.
DOI: 10.1056/NEJMc2211125
Databáze: MEDLINE